Journal of Korean Traditional Oncology (대한암한의학회지)

Korean Association of Traditional Oncology (대한암한의학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of combined acupuncture and gabapentin treatment on chemotherapy-induced peripheral neuropathy: a pilot, randomized, assessor-blinded, controlled trial

  • Hyun Jung Jung (Department of Diagnostics, College of Korean Medicine, Daegu Haany University) ;
  • Dae Jun Kim (Department of Korean Internal Medicine, College of Korean Medicine, Daegu Haany University) ;
  • Joon Seok Byun (Department of Korean Internal Medicine, College of Korean Medicine, Daegu Haany University)
  • Received : 2023.10.21
  • Accepted : 2023.12.03
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

목적: 항암유발말초신경병증은 암 환자가 겪는 흔한 항암 부작용이나 현재까지 효과적으로 알려진 치료법은 없다. 본 연구의 목적은 항암유발말초신경병증에 대한 침 치료와 가바펜틴의 병용 요법의 효과와 안전성을 평가하는 것이다. 방법: 항암유발말초신경병증을 겪고 있는 24명의 암 환자를 침 치료 단독군 (AG, acupuncture group)과 침과 가바펜틴의 병용요법군 (CG, combined acupuncture and gabapentin group)으로 무작위 배정하였다. 두 그룹 모두 침 치료는 주 3회, 4주간 수행하였다. 병용 요법군은 침 치료와 더불어 1일 900mg의 가바펜틴을 복용하도록 하였다. 치료 효과는 Neuropathic Pain Symptom Inventory (NPSI), visual analogue scale (VAS), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20 items (EORTC-CIPN20)를 이용하여 측정하였다. 치료로 인한 부작용은 대상자가 방문할 때마다 조사하였다. 결과: 총 23명의 대상자(AG, n=12; CG, n=11)의 평가지표를 분석한 결과, 치료 4 주 후 침 치료 단독군은 NPSI 점수가 44.33±25.04에서 30.58±21.55으로 감소하였고, 병용 요법군은 30.55±25.59에서 18.64±19.42로 감소하였으며, 두 군 모두 통계적으로 유의미하게 감소하였다(p<0.001). VAS점수는 침 치료 단독군에서는 4.79±2.17 에서 3.42±2.49으로 감소하였고, 병용 요법군에서는 3.55±2.07에서 2.73±2.49 로 감소하였다(p<0.05). 치료 효과는 치료 완료 2주후까지 지속되었으며, 두 군간의 유의미한 차이는 없었다. EORTC-CIPN20은 침 치료 단독군은 30.27±18.87에서 20.84±16.35으로 감소하여(p<0.01), 두 군 모두에서 삶의 질이 향상되었다. 결론: 본 연구로 침 치료와 가바펜틴의 병용 요법이 항암유발말초신경병증 환자의 증상 및 삶의 질 개선에 효과적이며 안전한 치료법임을 확인하였다. 그러나 침 치료와 가바펜틴의 시너지 효과에 대해서는 확인 할 수 없었으며, 이를 확인하기 위해 추가적인 연구가 필요할 것으로 사료된다.

Keywords

Acknowledgement

This research was supported by a grant of Comprehensive and Integrative Medicine R&D project through Comprehensive and Integrative Medicine Institute (CIMI), funded by the Ministry of Health & Welfare (MOHW), Republic of Korea (Grant Number: 090-091-3000-3038-301-320-01).

References

  1. Yabro CH, Wujcik D, Gobel BH. Cancer Nursing: Principles and Practice, Jones & Bartlett Publishers, Sudbury, MA, 2010
  2. Christian M, Ingo D, Hans T, Tamara Q, Ralf B. Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin. Support Care Cancer 2021; 29(8):4223-4238 https://doi.org/10.1007/s00520-021-06042-x
  3. Cindy T, Constance V, Jason WB, Ian L. Results of a strength and balance training pilot study for colorectal cancer survivors with peripheral neuropathy caused by oxaliplatin. Rehabilitation Oncology 2014; 32(4):38-44 https://doi.org/10.1097/01893697-201432040-00007
  4. Oh PJ, Kim YL. Effectiveness of non-pharmacologic interventions in chemotherapy induced peripheral neuropathy: a systematic review and meta-analysis. J. Korean Acad Nurs 2018;48:123-142 https://doi.org/10.4040/jkan.2018.48.2.123
  5. Muhammad S, Fazal S, Nisar A, Robert DS. Efficacy of a topical gabapentin gel in a cisplatin paradigm of chemotherapy-induced peripheral neuropathy, BMC. Pharmacol Toxicol 2019;20(1):51
  6. Iravani S, Kazemi M, Emami RS, Shahi F, Wang J, Hou L, et al. Effectiveness of acupuncture treatment on chemotherapy-induced peripheral neuropathy: a pilot, randomized, assessor-blinded, controlled trial. Pain Res Manage 2020;2504674
  7. Samuels N, Ben-Arye E. Integrative approaches to chemotherapy-induced peripheral neuropathy. Curr Oncol Rep 2020;22:23
  8. Liu YW, Liu CT, Su Y.L, Tsai MY. A narrative review of complementary nutritional supplements for chemotherapy-induced peripheral neuropathy. Altern Ther Health Med 2020;26(4):43-49
  9. Zhang S, Wu T, Zhang H, Yang Y, Jiang H, Cao S, et al. Effect of electroacupuncture on chemotherapy-induced peripheral neuropathy in patients with malignant tumor: a single-blinded, randomized controlled trial. J Tradit Chin Med 2017;37(2):179-184 https://doi.org/10.1016/S0254-6272(17)30042-0
  10. Xiaoyan H, Lijuan W, Hongfei S, Gaofeng Z, Jingsong H, Wenjun W, et al. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma BMC Cancer 2017;17(1):40
  11. Ting B, Sujata P, Connie C, Iris WZ, Qing SL, Lauren P, et al. Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial. JAMA Netw Open 2020;3(3):e200681
  12. Alexander M, Lorna KS, Hui LC, T S K M, Sara CL, Wang CH, et al. A randomized assessor-blinded wait-list-controlled trial to assess the effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Integr Cancer Ther 2019;18:1534735419836501
  13. Chien TJ, Liu CY, Fang CJ, Kuo CY. The efficacy of acupuncture in chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis. Integr Cancer Ther 2019;18:1534735419886662
  14. Yuxia J, Yunxia W, Jiayuan Z, Xiao X, Qi Z. Efficacy and safety of acupuncture against chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2020;2020:8875433
  15. Lu W, Giobbie HA, Freedman RA, Shin IH, Lin NU, Partridge AH, et al. Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer survivors: a randomized controlled pilot trial. Oncologist 2020;25(4):310-318 https://doi.org/10.1634/theoncologist.2019-0489
  16. Qin W, Lijing J, Shengfei W, Peiqi C, Ling B, Di Z, et al. Adjuvant chemotherapy with Chinese herbal medicine formulas versus placebo in patients with lung adenocarcinoma after radical surgery: a multicenter, randomized, double-blind, placebo-controlled trial. Biol Proced Online 2020;22:5
  17. Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108(3):248-257 https://doi.org/10.1016/j.pain.2003.12.024
  18. Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 2005; 41(8):1135-1139 https://doi.org/10.1016/j.ejca.2005.02.012
  19. Zhao YX, Yu XC, Gao JH, Yao MJ, Zhu B. Acupuncture for paclitaxel-induced peripheral neuropathy: a review of clinical and basic studies. J Pain Res 2021;14:993-1005 https://doi.org/10.2147/JPR.S296150
  20. Feng YY, Fang YC, Wang YQ, Hao YM. Acupoint therapy on diabetes mellitus and its common chronic complications: a review of its mechanisms. Biomed Res Int 2018;2018:3128378
  21. Kim MJ, Lee JH, Jang JU, Quan FS, Kim SK, Kim WJ. The efficacy of combination treatment of gabapentin and electro-acupuncture on paclitaxel-induced neuropathic pain. Korean J Physiol Pharmacol 2017;21(6):657-666 https://doi.org/10.4196/kjpp.2017.21.6.657
  22. Caraceni A, Zecca E, Martini C, Conno FD. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage 1999;17(6):441-445 https://doi.org/10.1016/S0885-3924(99)00033-0
  23. Hu LY, Mi WL, Wu GC, Wang YQ, Mao QL. Prevention and treatment for chemotherapy-induced peripheral neuropathy: therapies based on CIPN mechanisms. Curr Neuropharmacol 2019;17(2):184-196 https://doi.org/10.2174/1570159X15666170915143217